Lite Strategy, Inc. Operating Lease Right-of-Use Assets
Lite Strategy, Inc. (LITS) had Operating Lease Right-of-Use Assets of $0 as of 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-09-26
- 2025-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2025-03-31: Operating Lease, Right-of-Use Asset $0.00.
- 2024-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2024-09-30: Operating Lease, Right-of-Use Asset $0.00.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $214.00K 10-K · filed 2025-09-26 |
| 2024-03-31 | $10.84M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $11.22M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $11.60M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.97M 10-K · filed 2024-09-19 |
| 2023-03-31 | $12.34M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $12.70M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $13.05M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.05M 10-K · filed 2023-09-26 |
| 2022-03-31 | $9.52M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $7.33M 10-Q/A · filed 2022-05-23 |
| 2021-09-30 | $7.55M 10-Q/A · filed 2022-05-23 |
| 2021-06-30 | $7.77M 10-K · filed 2022-09-08 |
| 2021-03-31 | $7.99M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.21M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $8.42M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $0.00 10-K/A · filed 2022-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |